Literature DB >> 355578

Role of complement in host defense against experimental disseminated candidiasis.

J A Gelfand, D L Hurley, A S Fauci, M M Frank.   

Abstract

The role of complement in experimental disseminated candidiasis was studied in normal guinea pigs, animals congenitally deficient in the fourth component of complement (C4), and animals depleted of alternative pathway activity by cobra venom factor (CVF). Animals pretreated with CVF and challenged with Candida albicans had a high rate of mortality. Results of quantitative organ cultures corroborated prior reports that the kidney was the major target organ of infection. Infection of the kidney was markedly enhanced by CVF-induced depletion of the alternative pathway but not by classical pathway deficiency (deficiency in C4). There were differences among organs (kidney, liver, and spleen) in their requirement for complement to mount an effective host defense response. Ultimately, the integrity of the alternative pathway and late components of complement appears necessary for the limitation of and survival from sepsis due to C. albicans in nonimmune animals.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 355578     DOI: 10.1093/infdis/138.1.9

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Alternate complement pathway activation by group A streptococci: role of M-protein.

Authors:  A L Bisno
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

2.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.

Authors:  Mason X Zhang; M Charlotte Bohlman; Carol Itatani; Dennis R Burton; Paul W H I Parren; Stephen C St Jeor; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 4.  Host-parasite interaction in fungal infections.

Authors:  N Khardori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

5.  Alterations in lung macrophage antimicrobial activity associated with viral pneumonia.

Authors:  G A Warr; G J Jakab
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

6.  Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.

Authors:  Gayle M Boxx; Thomas R Kozel; Casey T Nishiya; Mason X Zhang
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

7.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

8.  Activation and binding of C3 by Candida albicans.

Authors:  T R Kozel; R R Brown; G S Pfrommer
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

9.  Activation of the alternative complement pathway by Sporothrix schenckii.

Authors:  E N Scott; H G Muchmore; D P Fine
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

10.  Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model.

Authors:  Donna M MacCallum
Journal:  FEMS Yeast Res       Date:  2009-10       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.